Community lists
Curata · Sanità

Lab tools & diagnostics

Di InspectStocksPublished 14 ott 202620 companies0 followers

Instruments, supplies and testing services for labs, drugmakers and doctors.

Raggruppate con l’aiuto di un modello di IA e riviste dalla nostra redazione. La riga sotto ogni azienda spiega perché è qui.

I prezzi delle azioni sono quelli di chiusura del 11 nov 2026, dal feed della borsa IEX.

Grade mix

A 8B 8C 2D 1F 1

Revenue growing

19 of 20

Free cash flow growing

9 of 20

Median price move, 1 year

+22,0%

  • TMOTHERMO FISHER SCIENTIFIC INC.

    Diagnostics and researchMarket cap 265,9B USDP/E 37,85

    717,62 USD+22,5%1Y

    Since added +8,2%

    A+
    Crescita e cassa
    Cresce con forza
    Business trend
    In accelerazione
    Business quality
    Forte
    Getting better
    In miglioramento

    Revenue

    47,4B USD+8,3%

    Profit

    7,1B USD+7,6%

    Free cash flow

    7,6B USD+24,3%
    Why it is here: Sells lab instruments, reagents and services to researchers and drug makers
  • DHRDANAHER CORPORATION

    Diagnostics and researchMarket cap 165,5B USDP/E 38,51

    235,31 USD+8,0%1Y

    Since added +5,4%

    B+
    Crescita e cassa
    Cresce con forza
    Business trend
    In accelerazione
    Business quality
    Forte
    Getting better
    In miglioramento

    Revenue

    25,6B USD+5,5%

    Profit

    4,3B USD+23,6%

    Free cash flow

    5,7B USD+14,2%
    Why it is here: Sells research instruments, supplies and services
  • AAGILENT TECHNOLOGIES, INC.

    Diagnostics and researchMarket cap 49,9B USDP/E 34,89

    176,91 USD+17,6%1Y

    Since added +3,1%

    B+
    Crescita e cassa
    Cresce con forza
    Business trend
    In accelerazione
    Business quality
    Forte
    Getting better
    In miglioramento

    Revenue

    7,4B USD+8,6%

    Profit

    1,4B USD+18,0%

    Free cash flow

    1,3B USD+16,5%
    Why it is here: Sells lab instruments, consumables and software to labs and drug makers
  • WATWaters Corporation

    Diagnostics and researchMarket cap 46,3B USDP/E 202,08

    470,84 USD+21,5%1Y

    Since added +9,7%

    D
    Crescita e cassa
    In crescita
    Business trend
    In rallentamento
    Business quality
    Mista
    Getting better
    Misto

    Revenue

    5,6B USD+84,2%

    Profit

    98,6M USD-84,8%

    Free cash flow

    290,8M USD-51,7%
    Why it is here: Sells liquid chromatography and mass spectrometry instruments and consumables
  • MTDMettler-Toledo International Inc.

    Diagnostics and researchMarket cap 34,8B USDP/E 37,95

    1749,30 USD+20,8%1Y

    Since added +9,4%

    B+
    Crescita e cassa
    Cresce con forza
    Business trend
    Stabile
    Business quality
    Forte
    Getting better
    In miglioramento

    Revenue

    4,2B USD+6,5%

    Profit

    934,1M USD+11,8%

    Free cash flow

    870,6M USD-2,1%
    Why it is here: Makes precision laboratory instruments and weighing equipment
  • ILMNIllumina, Inc.

    Diagnostics and researchMarket cap 32,2B USDP/E 36,64

    212,86 USD+74,5%1Y

    Since added -21,5%

    A+
    Crescita e cassa
    Cresce con forza
    Business trend
    Stabile
    Business quality
    Forte
    Getting better
    Migliora nettamente

    Revenue

    4,5B USD+5,8%

    Profit

    895M USD+27,5%

    Free cash flow

    1,1B USD+5,7%
    Why it is here: Sells DNA sequencing instruments and reagents
  • IDXXIDEXX LABORATORIES INC /DE

    Diagnostics and researchMarket cap 55,4B USDP/E 47,37

    703,00 USD-1,5%1Y

    Since added +35,2%

    A+
    Crescita e cassa
    Cresce con forza
    Business trend
    Stabile
    Business quality
    Forte
    Getting better
    Migliora nettamente

    Revenue

    4,7B USD+11,9%

    Profit

    1,2B USD+15,1%

    Free cash flow

    1,3B USD+35,3%
    Why it is here: Sells veterinary diagnostic tests and instruments
  • DGXQuest Diagnostics Inc

    Diagnostics and researchMarket cap 28,5B USDP/E 25,77

    258,72 USD+40,8%1Y

    Since added +12,2%

    A
    Crescita e cassa
    Cresce con forza
    Business trend
    Stabile
    Business quality
    Solida
    Getting better
    In miglioramento

    Revenue

    11,8B USD+9,1%

    Profit

    1,1B USD+16,5%

    Free cash flow

    1,4B USD-1,3%
    Why it is here: Provides diagnostic testing and clinical lab services
  • LHLABCORP HOLDINGS INC.

    Diagnostics and researchMarket cap 30,2B USDP/E 30,53

    372,18 USD+41,3%1Y

    Since added +18,7%

    A
    Crescita e cassa
    Cresce con forza
    Business trend
    Stabile
    Business quality
    Mista
    Getting better
    Migliora nettamente

    Revenue

    14,6B USD+6,0%

    Profit

    1B USD+17,4%

    Free cash flow

    1,3B USD-6,8%
    Why it is here: Provides diagnostic tests and clinical lab services
  • RVTYREVVITY, INC

    Diagnostics and researchMarket cap 17,7B USDP/E 70,32

    158,22 USD+68,5%1Y

    Since added +2,0%

    A
    Crescita e cassa
    Cresce con forza
    Business trend
    Stabile
    Business quality
    Mista
    Getting better
    In miglioramento

    Revenue

    2,9B USD+4,6%

    Profit

    253,2M USD+6,6%

    Free cash flow

    590,5M USD+18,7%
    Why it is here: Sells lab instruments, reagents and diagnostics tools to research and drug makers
  • IQVIQVIA HOLDINGS INC.

    Diagnostics and researchMarket cap 45,2B USDP/E 33,38

    274,37 USD+24,2%1Y

    Since added +5,2%

    A
    Crescita e cassa
    Cresce con forza
    Business trend
    Stabile
    Business quality
    Mista
    Getting better
    In miglioramento

    Revenue

    17,3B USD+8,8%

    Profit

    1,4B USD+8,7%

    Free cash flow

    2,1B USD-6,0%
    Why it is here: Runs clinical trials and sells healthcare data to drugmakers
  • NTRANATERA, INC.

    Diagnostics and researchMarket cap 46,4B USDNessun P/E (perdita operativa)

    319,77 USD+52,6%1Y

    Since added -19,2%

    B-
    Crescita e cassa
    Cresce con forza
    Business trend
    Stabile
    Business quality
    Debole
    Getting better
    Misto

    Revenue

    2,9B USD+37,4%

    Profit

    -164,7M USD+46,7%

    Free cash flow

    52,5M USD-50,5%
    Why it is here: Provides genetic and cell-free DNA diagnostic tests
  • TECHBIO-TECHNE Corp

    BiotechnologyMarket cap 11,4B USDP/E 66,77

    72,78 USD+19,2%1Y

    Since added +0,4%

    A+
    Crescita e cassa
    Cresce con forza
    Business trend
    In accelerazione
    Business quality
    Forte
    Getting better
    Migliora nettamente

    Revenue

    1,2B USD+0,9%

    Profit

    172M USD+120,5%

    Free cash flow

    308,2M USD+37,6%
    Why it is here: Sells proteins, antibodies and diagnostic reagents to researchers
  • BRKRBRUKER CORPORATION

    Medical devicesMarket cap 9,5B USDNessun P/E (perdita operativa)

    62,41 USD+47,5%1Y

    Since added +11,0%

    B
    Crescita e cassa
    Cresce con forza
    Business trend
    In rallentamento
    Business quality
    Mista
    Getting better
    Misto

    Revenue

    3,5B USD+2,2%

    Profit

    -123,4M USD-490,4%

    Free cash flow

    244,7M USD+2408,5%
    Why it is here: Makes scientific instruments for microscopy, spectroscopy and magnetic resonance research
  • RGENREPLIGEN CORP

    Medical instruments and suppliesMarket cap 9,8B USDNo P/E

    172,68 USD+9,3%1Y

    Since added -1,6%

    B
    Crescita e cassa
    Cresce con forza
    Business trend
    In rallentamento
    Business quality
    Mista
    Getting better
    In miglioramento

    Revenue

    805,6M USD+13,8%

    Profit

    -11,8M USD-779,2%

    Free cash flow

    106,7M USD-3,0%
    Why it is here: Supplies bioprocessing filtration, chromatography and protein products to biologic drug makers
  • BIOBIO-RAD LABORATORIES, INC.

    Medical devicesMarket cap 10,4B USDNessun P/E (perdita operativa)

    386,08 USD+18,0%1Y

    Since added +6,1%

    C
    Crescita e cassa
    In crescita
    Business trend
    Stabile
    Business quality
    Solida
    Getting better
    In miglioramento

    Revenue

    2,6B USD+1,4%

    Profit

    1B USD+251,3%

    Free cash flow

    329,1M USD-2,3%
    Why it is here: Sells life science research tools and clinical diagnostics reagents and instruments
  • QGENQIAGEN N.V.

    Diagnostics and researchMarket cap 10,9B USDP/E 25,93

    50,30 USD+19,8%1Y

    Since added +10,7%

    B+
    Crescita e cassa
    Cresce con forza
    Business trend
    Stabile
    Business quality
    Forte
    Getting better
    In miglioramento

    Revenue

    2,1B USD+2,1%

    Profit

    384,5M USD-5,2%

    Free cash flow

    436,2M USD-8,9%
    Why it is here: Supplies sample preparation and molecular testing kits and instruments
  • GHGUARDANT HEALTH, INC.

    Diagnostics and researchMarket cap 20,9B USDNessun P/E (perdita operativa)

    154,76 USD+58,2%1Y

    Since added -4,5%

    B
    Crescita e cassa
    Cresce con forza
    Business trend
    Stabile
    Business quality
    Mista
    Getting better
    Misto

    Revenue

    1,3B USD+41,7%

    Profit

    -485,1M USD-21,6%

    Free cash flow

    -232,1M USD+11,5%
    Why it is here: Provides blood-based cancer diagnostic tests
  • MEDPMedpace Holdings, Inc.

    Diagnostics and researchMarket cap 18,6B USDP/E 36,90

    664,52 USD+11,2%1Y

    Since added +9,0%

    C+
    Crescita e cassa
    Cresce con forza
    Business trend
    In rallentamento
    Business quality
    Forte
    Getting better
    Migliora nettamente

    Revenue

    2,8B USD+20,4%

    Profit

    517,8M USD+19,6%

    Free cash flow

    667,6M USD-1,4%
    Why it is here: Runs clinical trials for biotech and pharma drug developers
  • CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.

    Diagnostics and researchMarket cap 16,4B USDP/E 353,20

    342,61 USD+99,8%1Y

    Since added +14,5%

    F
    Crescita e cassa
    Misto
    Business trend
    In contrazione
    Business quality
    Mista
    Getting better
    Misto

    Revenue

    4B USD-1,2%

    Profit

    40,2M USD+148,8%

    Free cash flow

    399,6M USD-26,5%
    Why it is here: Provides preclinical research models and testing services to drug developers

Green and red compare each figure with the same window a year earlier. Grades and checks are the company page's own; nothing here is a recommendation.

DiscussionNo comments yet

Sign in to join the discussion

Be civil and stick to the companies. Comments are opinions, not advice.

    Lists are their owners' own, and notes and comments are opinions. Grades describe businesses from their filings; nothing here is a recommendation to buy or sell.